Liu Guangyu

Professional Biography

Dr. Liu Guangyu is Chief Physician in Breast Surgery at Fudan University Shanghai Cancer Center, Shanghai. Liu serves as Administrative Vice Director, Breast Surgery Department. Clinical expertise includes Breast cancer, Breast reconstruction, Benign breast disease. Co-investigator in FUSCC's FUTURE-SUPER trial — a landmark multi-cohort Phase 2 randomized study on first-line subtyping-based therapy for triple-negative breast cancer (TNBC), published in Lancet Oncology (2024) and representing FUSCC's leading position in TNBC precision medicine. Visiting Scholar, MD Anderson Cancer Center, University of Texas (2006–2007). 60+ published papers (34 SCI-indexed); contributor to 10 oncology textbooks; co-author on Lancet Oncology TNBC FUTURE-SUPER trial (2024).